Publication | Closed Access

Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisMedicineVascular BiologyPlatelet AntagonistPharmacologyCardiologyCoronary Artery Disease